Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/18452145

Download in:

View as

General Info

PMID
18452145